ALA Diagnostics develops a kit to diagnose Multiple Sclerosis.
ALA Diagnostics has raised $1.2M in total funding. The most recent round was Seed. The last funding was announced in June 2023.
ALA Diagnostics's investors include European Innovation Council, BeAble Capital.
ALA Diagnostics is headquartered in Madrid, Spain.
ALA Diagnostics develops a kit to diagnose Multiple Sclerosis.
ALA Diagnostics is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"ALA Diagnostics — Funding & Investors." VCBacked, June 22, 2023, https://www.vcbacked.co/company/ala-diagnostics. Accessed July 20, 2026.
VCBacked. (2023). ALA Diagnostics — Funding & Investors. Retrieved July 20, 2026, from https://www.vcbacked.co/company/ala-diagnostics
{{cite web |title=ALA Diagnostics — Funding & Investors |url=https://www.vcbacked.co/company/ala-diagnostics |website=VCBacked |access-date=July 20, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated